Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 398-399
DOI: 10.1111/apt.70780 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 10.06.2026. Verfasst von Elyke H Visser und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, the Netherlands. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AbbVie, Celltrion, Dr. Falk Pharma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, the Netherlands.
- Department of Gastroenterology & Hepatology, Erasmus MC, Rotterdam, the Netherlands.
- Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.
- Department of General Practice, Erasmus MC, Rotterdam, the Netherlands.
- Department of Gastroenterology & Hepatology, Amphia Hospital, Breda, the Netherlands.
- Department of Gastroenterology & Hepatology, IJsselland Hospital, Capelle aan de IJssel, the Netherlands.
ORCID-Profile: Elyke H Visser
Förderung
- AbbVie
- Celltrion
- Dr. Falk Pharma
- Ferring
- Galápagos
- Janssen Pharmaceuticals
- Eli Lilly and Company
- Pfizer
Zitieren
APA
Visser, E. H., Voshaar, M. A. O., van Linschoten, R. C. A., Bodelier, A. G. L., Fitzpatrick, C., de Jonge, V., Vermeulen, H., Verweij, K. E., van der Wiel, S., van der Horst, D., van der Woude, C. J., West, R. L., & van Noord, D. (2026). Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(3), 398-399. https://doi.org/10.1111/apt.70780
Vancouver
Visser EH, Voshaar MAO, van Linschoten RCA, Bodelier AGL, Fitzpatrick C, de Jonge V, et al. Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(3):398-399. doi:10.1111/apt.70780
BibTeX
@article{Visser2026,
author = {Visser, Elyke H and Voshaar, Martijn A Oude and van Linschoten, Reinier C A and Bodelier, Alexander G L and Fitzpatrick, Claire and de Jonge, Vincent and Vermeulen, Hestia and Verweij, K Evelyne and van der Wiel, Sanne and van der Horst, Daniëlle and van der Woude, C Janneke and West, Rachel L and van Noord, Desiree},
title = {Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {3},
pages = {398--399},
doi = {10.1111/apt.70780}
}
EUVIMED